Thomas James is an Associate Principal Scientist at AstraZeneca with 11 years’ experience translating academic excellence in synthetic organic chemistry into drug discovery, particularly in asymmetric catalysis and small-molecule modulation of protein–protein interactions. He holds a PhD in Organic Chemistry from the University of Leeds and completed postdoctoral work in asymmetric organocatalysis at the Max Planck Institute, bringing deep mechanistic insight to medicinal chemistry programs. At Leeds he led research on disease-relevant PPIs and subsequently advanced discovery projects at AstraZeneca, progressing from senior scientist to his current leadership role. Known for combining rigorous synthetic expertise with practical drug discovery instincts, he often bridges academia and industry to accelerate hit-to-lead efforts. An early industry exposure at Roche and a first-class MChem in Medicinal Chemistry underpin his strong foundation in translational research.
11 years of coding experience
4 years of employment as a software developer
Postdoctoral Research Fellow, Asymmetric Organocatalysis, Postdoctoral Research Fellow, Asymmetric Organocatalysis at Max Planck Society
Doctor of Philosophy (PhD), Organic Chemistry, Doctor of Philosophy (PhD), Organic Chemistry at University of Leeds
UCLCHEM - A gas-grain chemical code for Astrochemistry.
Contributions:2 PRs, 13 pushes, 1 branch in 1 year 2 months
chemicalastrochemistrygasgrain
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.